Literature DB >> 25157329

Insights in public health: The hidden epidemic: sexually transmitted diseases in 2014.

Alan R Katz1.   

Abstract

Diseases caused by sexually transmitted agents are among the most common infectious diseases in the United States. Sexually transmitted diseases (STDs) have serious sequelae including physical pain, emotional distress, adverse reproductive outcomes, and cancer. They also pose an economic burden on society. STDs are challenging to prevent and control due to a general reluctance to address sexual health issues in an open manner. Human papillomavirus infection, chlamydia, and gonorrhea have recently been addressed by the Centers for Disease Control and Prevention in their Grand Rounds series reflecting their high-profile status on the national prevention and control agenda. This Insights column will focus on these three STDs.

Entities:  

Mesh：

Year:  2014        PMID： 25157329      PMCID： PMC4142582     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN： 2165-8242


  25 in total

1.  Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-23       Impact factor: 17.586

2.  The emerging threat of untreatable gonococcal infection.

Authors:  Gail A Bolan; P Frederick Sparling; Judith N Wasserheit
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

3.  Comparative model-based analysis of screening programs for Chlamydia trachomatis infections.

Authors:  M Kretzschmar; R Welte; A van den Hoek; M J Postma
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

Review 4.  Priorities among effective clinical preventive services: results of a systematic review and analysis.

Authors:  Michael V Maciosek; Ashley B Coffield; Nichol M Edwards; Thomas J Flottemesch; Michael J Goodman; Leif I Solberg
Journal:  Am J Prev Med       Date:  2006-07       Impact factor: 5.043

5.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

6.  CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-04-01       Impact factor: 17.586

7.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

8.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

9.  Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.

Authors:  M Unemo; D Golparian; A Hestner
Journal:  Euro Surveill       Date:  2011-02-10

10.  Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.

Authors:  Makoto Ohnishi; Takeshi Saika; Shinji Hoshina; Kazuhiro Iwasaku; Shu-ichi Nakayama; Haruo Watanabe; Jo Kitawaki
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883
View more
  1 in total

1.  The prevalence of Chlamydia trachomatis infection among Saudi women attending the infertility clinic in Central Saudi Arabia.

Authors:  Dunia A Alfarraj; Ali M Somily; Rasheed M Alssum; Zeinab M Abotalib; Amal A El-Sayed; Hazim H Al-Mandeel
Journal:  Saudi Med J       Date:  2015-01       Impact factor: 1.484
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.